Benzinga's Top Ratings Upgrades, Downgrades For March 16, 2022

Upgrades

Bernstein upgraded the previous rating for Stryker Corp SYK from Market Perform to Outperform. For the fourth quarter, Stryker had an EPS of $2.71, compared to year-ago quarter EPS of $2.81. At the moment, the stock has a 52-week-high of $281.16 and a 52-week-low of $227.84. Stryker closed at $254.34 at the end of the last trading period.

For Edwards Lifesciences Corp EW, Bernstein upgraded the previous rating of Market Perform to Outperform. Edwards Lifesciences earned $0.51 in the fourth quarter, compared to $0.50 in the year-ago quarter. At the moment, the stock has a 52-week-high of $131.73 and a 52-week-low of $78.44. Edwards Lifesciences closed at $106.15 at the end of the last trading period.

According to Morgan Stanley, the prior rating for KE Holdings Inc BEKE was changed from Equal-Weight to Overweight. KE Holdings earned $0.01 in the fourth quarter, compared to $0.26 in the year-ago quarter. At the moment, the stock has a 52-week-high of $72.49 and a 52-week-low of $7.31. KE Holdings closed at $9.06 at the end of the last trading period.

Northcoast Research upgraded the previous rating for Wingstop Inc WING from Neutral to Buy. For the fourth quarter, Wingstop had an EPS of $0.24, compared to year-ago quarter EPS of $0.18. The current stock performance of Wingstop shows a 52-week-high of $187.35 and a 52-week-low of $110.54. Moreover, at the end of the last trading period, the closing price was at $113.24.

For Magna International Inc MGA, Raymond James upgraded the previous rating of Underperform to Market Perform. In the fourth quarter, Magna International showed an EPS of $1.30, compared to $2.83 from the year-ago quarter. The current stock performance of Magna International shows a 52-week-high of $104.28 and a 52-week-low of $54.60. Moreover, at the end of the last trading period, the closing price was at $58.33.

Deutsche Bank upgraded the previous rating for Novo Nordisk A/S NVO from Hold to Buy. Novo Nordisk earned $0.73 in the fourth quarter, compared to $0.64 in the year-ago quarter. The stock has a 52-week-high of $117.35 and a 52-week-low of $66.59. At the end of the last trading period, Novo Nordisk closed at $102.45.

For Micron Technology Inc MU, Bernstein upgraded the previous rating of Market Perform to Outperform. Micron Technology earned $2.16 in the first quarter, compared to $0.78 in the year-ago quarter. The current stock performance of Micron Technology shows a 52-week-high of $98.45 and a 52-week-low of $65.67. Moreover, at the end of the last trading period, the closing price was at $73.11.

According to JP Morgan, the prior rating for Starbucks Corp SBUX was changed from Neutral to Overweight. For the first quarter, Starbucks had an EPS of $0.72, compared to year-ago quarter EPS of $0.61. The stock has a 52-week-high of $126.32 and a 52-week-low of $78.92. At the end of the last trading period, Starbucks closed at $83.12.

For Ultragenyx Pharmaceutical Inc RARE, Credit Suisse upgraded the previous rating of Neutral to Outperform. In the fourth quarter, Ultragenyx Pharmaceutical showed an EPS of $1.79, compared to $0.37 from the year-ago quarter. At the moment, the stock has a 52-week-high of $133.82 and a 52-week-low of $61.20. Ultragenyx Pharmaceutical closed at $63.69 at the end of the last trading period.

According to Canaccord Genuity, the prior rating for ACADIA Pharmaceuticals Inc ACAD was changed from Hold to Buy. For the fourth quarter, ACADIA Pharmaceuticals had an EPS of $0.27, compared to year-ago quarter EPS of $0.42. At the moment, the stock has a 52-week-high of $30.16 and a 52-week-low of $15.68. ACADIA Pharmaceuticals closed at $23.05 at the end of the last trading period.

Raymond James upgraded the previous rating for Host Hotels & Resorts Inc HST from Market Perform to Outperform. In the fourth quarter, Host Hotels & Resorts showed an EPS of $0.29, compared to $0.02 from the year-ago quarter. The stock has a 52-week-high of $19.75 and a 52-week-low of $14.67. At the end of the last trading period, Host Hotels & Resorts closed at $18.15.

See all analyst ratings upgrades.

Downgrades

According to Bernstein, the prior rating for Johnson & Johnson JNJ was changed from Outperform to Market Perform. For the fourth quarter, Johnson & Johnson had an EPS of $2.13, compared to year-ago quarter EPS of $1.86. At the moment, the stock has a 52-week-high of $179.92 and a 52-week-low of $155.72. Johnson & Johnson closed at $176.14 at the end of the last trading period.

Alliance Global Partners downgraded the previous rating for Entasis Therapeutics Holdings Inc ETTX from Buy to Neutral. Entasis Therapeutics Hldg earned $0.25 in the fourth quarter, compared to $0.13 in the year-ago quarter. The current stock performance of Entasis Therapeutics Hldg shows a 52-week-high of $3.88 and a 52-week-low of $1.40. Moreover, at the end of the last trading period, the closing price was at $1.86.

For SoFi Technologies Inc SOFI, Morgan Stanley downgraded the previous rating of Overweight to Equal-Weight. The current stock performance of SoFi Technologies shows a 52-week-high of $24.95 and a 52-week-low of $7.74. Moreover, at the end of the last trading period, the closing price was at $8.20.

National Bank Of Canada downgraded the previous rating for SSR Mining Inc SSRM from Outperform to Sector Perform. For the fourth quarter, SSR Mining had an EPS of $0.44, compared to year-ago quarter EPS of $0.50. The current stock performance of SSR Mining shows a 52-week-high of $22.45 and a 52-week-low of $13.68. Moreover, at the end of the last trading period, the closing price was at $21.23.

See all analyst ratings downgrades.

Initiations

SMBC Nikko initiated coverage on Jounce Therapeutics Inc JNCE with an Outperform rating. The price target for Jounce Therapeutics is set to $17.00. Jounce Therapeutics earned $0.59 in the fourth quarter, compared to $0.86 in the year-ago quarter. At the moment, the stock has a 52-week-high of $12.80 and a 52-week-low of $5.03. Jounce Therapeutics closed at $6.89 at the end of the last trading period.

With an Outperform rating, SMBC Nikko initiated coverage on Inhibrx Inc INBX. The price target seems to have been set at $40.00 for Inhibrx. For the fourth quarter, Inhibrx had an EPS of $0.55, compared to year-ago quarter EPS of $0.47. The current stock performance of Inhibrx shows a 52-week-high of $47.90 and a 52-week-low of $14.27. Moreover, at the end of the last trading period, the closing price was at $20.18.

With a Buy rating, Spartan Securities Group initiated coverage on BitNile Holdings Inc NILE. The price target seems to have been set at $7.00 for BitNile Holdings. In the third quarter, BitNile Holdings showed an EPS of $0.73, compared to $0.40 from the year-ago quarter. At the moment, the stock has a 52-week-high of $1.76 and a 52-week-low of $0.50. BitNile Holdings closed at $0.53 at the end of the last trading period.

With a Buy rating, Craig-Hallum initiated coverage on Cepton Inc CPTN. The price target seems to have been set at $19.00 for Cepton. The current stock performance of Cepton shows a 52-week-high of $80.16 and a 52-week-low of $4.27. Moreover, at the end of the last trading period, the closing price was at $4.28.

Maxim Group initiated coverage on Unicycive Therapeutics Inc UNCY with a Buy rating. The price target for Unicycive Therapeutics is set to $3.00. For the third quarter, Unicycive Therapeutics had an EPS of $0.34, compared to year-ago quarter EPS of $0.08. The current stock performance of Unicycive Therapeutics shows a 52-week-high of $8.73 and a 52-week-low of $0.87. Moreover, at the end of the last trading period, the closing price was at $1.07.

EF Hutton initiated coverage on Gladstone Commercial Corp GOOD with a Buy rating. The price target for Gladstone Commercial is set to $24.00. Gladstone Commercial earned $0.40 in the fourth quarter, compared to $0.39 in the year-ago quarter. The stock has a 52-week-high of $26.13 and a 52-week-low of $18.94. At the end of the last trading period, Gladstone Commercial closed at $21.49.

With an Overweight rating, Morgan Stanley initiated coverage on Constellation Energy Corp CEG. The price target seems to have been set at $63.00 for Constellation Energy. At the moment, the stock has a 52-week-high of $56.57 and a 52-week-low of $42.18. Constellation Energy closed at $51.29 at the end of the last trading period.

Benchmark initiated coverage on Expeditors International of Washington Inc EXPD with a Hold rating. Expeditors International earned $2.66 in the fourth quarter, compared to $1.16 in the year-ago quarter. The stock has a 52-week-high of $137.80 and a 52-week-low of $97.37. At the end of the last trading period, Expeditors International closed at $99.49.

See all analyst ratings initiations.